sign free newsletters sign free newsletters preliminary data immunization 94 percent effective prevent severe infections good news comes threes time week coronavirus vaccine developer reported preliminary results suggesting vaccine highly effective today biotech company moderna cambridge massachusetts reported rna based vaccine 94 effective preventing covid-19 based analysis 95 cases ongoing phase iii efficacy trial scientists press released results share details week working rival rna vaccine moderna released figures suggesting vaccine likely prevent severe covid-19 infections not clear developers announcements need peer reviewed data standards looks like good news says daniel altmann immunologist imperial college london results trial truly striking says